Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells

Journal of Laboratory and Clinical Medicine

Volumn 147, Issue 6, 2006, Pages 281-289

  Fragopoulou, Elizabeth ^a   Iatrou, Christos ^b   Antonopoulou, Smaragdi ^c   Ruan, Xiong Zhong ^d   Fernando, Ray L ^d   Powis, Stephen H ^d   Moorhead, John F ^d   Varghese, Zac ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c HAROKOPIO UNIVERSITY   (Greece)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OIL RED O; RECEPTOR SUBUNIT; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR AI; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; FOAM CELL; GENE CONTROL; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIPID STORAGE; MESANGIUM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

CELL LINE, TRANSFORMED; CHOLESTEROL, LDL; FOAM CELLS; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LIPID METABOLISM; MESANGIAL CELLS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LDL; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A; TRITIUM;

EID: 33646913594     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2006.01.004     Document Type: Article

References (44)

1. Demopoulos C.A., Pinckard R.N., and Hanahan D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 254 (1979) 9355-9358
2. Evangelou A.M. Platelet-activating factor (PAF). implications for coronary heart and vascular diseases. Prostaglandins Leukot Essent Fatty Acids 50 (1994) 1-28
3. Dentan C., Lesnik P., Chapman M.J., and Ninio E. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur J Biochem 236 (1996) 48-55
4. Demopoulos C.A., Karantonis H.C., and Antonopoulou S. Platelet activating factor-a molecular link between atherosclerosis theories. Eur J Lipid Sci Technol 105 (2003) 705-716
5. Schlondorff D., and Neuwirth R. Platelet-activating factor and the kidney. Am J Physiol 251 (1986) F1-F11
6. Ortiz A., Gomez-Chiarri M., Lerma J.L., Gonzalez E., and Egido J. The role of platelet-activating factor (PAF) in experimental glomerular injury. Lipids 26 (1991) 1310-1315
7. Camussi G. Potential role of platelet-activating factor in renal pathophysiology. Kidney Int 29 (1986) 469-477
8. Camussi G., Tetta C., Coda R., Segoloni G.P., and Vercellone A. Platelet-activating factor-induced loss of glomerular anionic charges. Kidney Int 25 (1984) 73-81
9. Lopez-Novoa J.M. Potential role of platelet activating factor in acute renal failure. Kidney Int 55 (1999) 1672-1682
10. Iatrou C., Moustakas G., Antonopoulou S., Demopoulos C.A., and Ziroyiannis P. Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Nephron 72 (1996) 611-616
11. Denizot Y., Aupetit C., Bridoux F., Alphonse J.C., Cogne M., and Aldigier J.C. Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy. [In Process Citation]. Nephrol Dial Transplant 15 (2000) 1344-1347
12. Noris M., Benigni A., Boccardo P., Gotti E., Benfenati E., Aiello S., et al. Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis. Kidney Int 43 (1993) 426-429
13. Kester M., Thomas C.P., Wang J., and Dunn M.J. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells. J Cell Physiol 153 (1992) 244-255
14. Ruiz-Ortega M., Bustos C., Plaza J.J., and Egido J. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. Nephrol Dial Transplant 13 (1998) 886-892
15. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
16. Steinberg D. Atherogenesis in perspective. hypercholesterolemia and inflammation as partners in crime. Nat Med 8 (2002) 1211-1217
17. Liapikos T.A., Antonopoulou S., Karabina S.P., Tsoukatos D.C., Demopoulos C.A., and Tselepis A.D. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Bba-Lipid Lipid Metab 1212 (1994) 353-360
18. Benveniste J. Paf-acether, an ether phospho-lipid with biological activity. Prog Clin Biol Res 282 (1988) 73-85
19. Mueller H.W., Haught C.A., McNatt J.M., Cui K., Gaskell S.J., Johnston D.A., et al. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ Res 77 (1995) 54-63
20. Subbanagounder G., Leitinger N., Shih P.T., Faull K.F., and Berliner J.A. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis. in vitro and in vivo inhibition by WEB 2086. Circ Res 85 (1999) 311-318
21. Feliste R., Perret B., Braquet P., and Chap H. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. Atherosclerosis 78 (1989) 151-158
22. Diamond J.R., and Karnovsky M.J. Focal and segmental glomerulosclerosis. analogies to atherosclerosis. Kidney Int 33 (1988) 917-924
23. Keane W.F., Kasiske B.L., and O'Donnell M.P. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 8 (1988) 261-271
24. Ruan X.Z., Varghese Z., Powis S.H., and Moorhead J.F. Dysregulation of LDL receptor under the influence of inflammatory cytokines. a new pathway for foam cell formation. Kidney Int 60 (2001) 1716-1725
25. Li H., Freeman M.W., and Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 95 (1995) 122-133
26. Ruan X.Z., Varghese Z., Powis S.H., and Moorhead J.F. Human mesangial cells express inducible macrophage scavenger receptor. an Ap-1 and ets mediated response. Kidney Int.Suppl 71 (1999) S163-S166
27. Sraer J.D., Delarue F., Hagege J., Feunteun J., Pinet F., Nguyen G., et al. Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int 49 (1996) 267-270
28. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-269
29. Bradford M.M., and Williams W.L. New, rapid, sensitive method for protein determination. Fed Proc 35 (1976) 274
30. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
31. Rouis M., Nigon F., and Chapman M.J. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. Biochem Biophys Res Commun 156 (1988) 1293-1301
32. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349 (1991) 342-346
33. Nakamura M., Honda Z., Izumi T., Sakanaka C., Mutoh H., Minami M., et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 266 (1991) 20400-20405
34. Chao W., and Olson M.S. Platelet-activating factor. receptors and signal transduction. Biochem J 292 Pt 3 (1993) 617-629
35. Honda Z., Takano T., Gotoh Y., Nishida E., Ito K., and Shimizu T. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J Biol Chem 269 (1994) 2307-2315
36. Mutoh H., Bito H., Minami M., Nakamura M., Honda Z., Izumi T., et al. Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor. Febs Lett 322 (1993) 129-134
37. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
38. Wheeler D.C., Fernando R.L., Gillett M.P., Zaruba J., Persaud J., Kingstone D., et al. Characterisation of the binding of low-density lipoproteins to cultured rat mesangial cells. Nephrol Dial Transplant 6 (1991) 701-708
39. Ruan X.Z., Varghese Z., Powis S.H., and Moorhead J.F. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int 56 (1999) 440-451
40. Ruan X.Z., Varghese Z., Fernando R., and Moorhead J.F. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 13 (1998) 1391-1397
41. Grone E.F., Abboud H.E., Hohne M., Walli A.K., Grone H.J., Stuker D., et al. Actions of lipoproteins in cultured human mesangial cells. modulation by mitogenic vasoconstrictors. Am J Physiol 263 (1992) F686-F696
42. Lee H.S., and Koh H.I. Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells. Lab Invest 71 (1994) 200-208
43. Takemura T., Yoshioka K., Aya N., Murakami K., Matumoto A., Itakura H., et al. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43 (1993) 918-927
44. Komatsu H., Ishiwari K., Shikata A., Nishida M., Kawakatsu H., and Sawada T. Platelet-activating factor induces cell growth through tyrosine phosphorylation pathway in cultured rat mesangial cells. Nippon Jinzo Gakkai Shi 37 (1995) 622-631